Ginkgo Bioworks
DNA
182 hedge funds and large institutions have $270M invested in Ginkgo Bioworks in 2025 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 51 increasing their positions, 41 reducing their positions, and 27 closing their positions.
245% more call options, than puts
Call options by funds: $7.06M | Put options by funds: $2.05M
93% more capital inflows, than outflows
Capital inflows: $50.6M | Capital outflows: $26.1M
30% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 27
24% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 41
4% more funds holding
Funds holding: 175 → 182 (+7)
2.95% more ownership
Funds ownership: 64.08% → 67.03% (+2.9%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
+$5.83M |
| 2 |
Morgan Stanley
New York
|
+$4.8M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.53M |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.86M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$2.77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$9.08M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$5.02M |
| 3 |
Erste Asset Management
Vienna,
Austria
|
-$2.15M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.47M |
| 5 |
SPX Gestao de Recursos
Rio De Janeiro,
Brazil
|
-$1.46M |
DNA Hedge Fund Activity: Q4 2025 in Review
182 of the 8,296 institutional investors tracked by Wall St. Rank reported a position in Ginkgo Bioworks (DNA) for Q4 2025, worth a combined $270M — down 38% from $437M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new DNA positions and 27 closed out — a net gain of 8 holders — while 51 added to existing stakes and 41 trimmed.
The largest buyer was Prescott Group Capital Management, opening a new position worth an estimated $5.83M. The largest seller was Baillie Gifford & Co, cutting an estimated $9.08M.
- 182 institutional investors held Ginkgo Bioworks (DNA) as of Q4 2025, up from 175 in Q3 2025.
- Funds reported $270M of Ginkgo Bioworks stock for Q4 2025, down 38% quarter-over-quarter.
- 35 funds opened new Ginkgo Bioworks positions in Q4 2025 and 27 closed out, a net change of +8 holders.
- The largest Ginkgo Bioworks buyer in Q4 2025 was Prescott Group Capital Management, an estimated $5.83M added.
- The largest Ginkgo Bioworks seller in Q4 2025 was Baillie Gifford & Co, an estimated $9.08M sold.
Based on aggregated 13F filings for Q4 2025.